At Boreal, we are committed to developing new technologies for blood-based detection and monitoring of circulating tumor DNA.

We are a team of specialists in molecular biology, engineering and physics with a passion to develop technology that advances next-generation sequencing to help cancer researchers and clinicians transform patient care through earlier detection and monitoring of cancer.

Through our first-generation SCODA platform technologies and our recent developments in Linked Molecule chemistries, Boreal is committed to creating faster, more efficient, and practical assays for routine clinical use.